Skip to main content
Connect with one of our Dutch experts
Get in touch
Osborne Clarke
en
en en
  • en en
  • nl nl
  • fr fr
  • de de
  • it it
  • es es
  • sv sv
  • pl pl
Search Close

Search results

  • Back
  • People
  • Expertise
    • Back
    • Transformation
      • Back
      • Decarbonisation
      • Digitalisation
      • Urban Dynamics
      • Data-driven business models: the role of legal teams in delivering success
    • Sectors
      • Back
      • Energy and Utilities
      • Financial Services
      • Life Sciences and Healthcare
      • Mobility and Infrastructure
      • Real Estate and Infrastructure
      • Retail and Consumer
      • Tech, Media and Comms
      • Workforce Solutions
      • All sectors
    • Services
      • Back
      • Banking and finance
      • Commercial
      • Competition, antitrust and trade
      • Corporate
      • Dispute resolution
      • Employment and pensions
      • ESG – Environmental, Social and Governance
      • Infrastructure services
      • Intellectual property
      • IT and data
      • Public law
      • Real estate
      • Regulatory and compliance
      • Tax
      • All Services
  • Osborne Clarke Solutions
  • Insights
    • Back
    • Headlines
    • Transformation
      • Back
      • Decarbonisation
      • Digitalisation
      • Urban Dynamics
    • Insights: sector
      • Back
      • Energy and Utilities
      • Financial services
      • Life Sciences and Healthcare
      • Real Estate and Infrastructure
      • Retail and Consumer
      • Tech, Media and Comms
      • Mobility and Infrastructure
      • Workforce Solutions
    • Insights: service
      • Back
      • Banking and finance
      • Commercial
      • Competition, antitrust and trade
      • Corporate
      • Dispute resolution
      • Employment and pensions
      • Infrastructure services
      • Intellectual property
      • IT and Data
      • Real Estate
      • Regulatory and Compliance
      • Tax
    • Key topics
      • Back
      • Blockchain
      • Brexit
      • ESG, Sustainability and Responsible Business
      • Elektromobilität
      • European Electronic Communication Code
      • GDPR
      • Global Compliance
      • Knowledge Notes
      • Managing Covid-19
      • Online Safety
      • Regulatory Outlook
      • Sanctions, ownership and related issues
      • Supply chains
      • Sustainable disruption: 12 decarbonising technologies for cities
      • The metaverse
      • The New Deal for Consumers
    • Events
    • All insights
  • Locations
    • Back
    • Belgium
    • China
    • France
    • Germany
    • India
    • Italy
    • The Netherlands
    • Poland
    • Singapore
    • Spain
    • Sweden
    • UK
    • US
    • View all locations
  • Careers
    • Back
    • Careers in Belgium
    • Careers in France
    • Careers in Germany
    • Careers in Italy
    • Careers in Poland
    • Careers in Spain
    • Careers in Sweden
    • Careers in the Netherlands
    • Careers in the UK
    • Careers in the US
    • View all careers
  • About us
    • Back
    • Helping you succeed in tomorrow's world
    • News
    • Osborne Clarke For Good
Close
Around the world
  • Belgium
  • China
  • France
  • Germany
  • India
  • Italy
  • The Netherlands
  • Poland
  • Singapore
  • Spain
  • Sweden
  • UK
  • US
View All Locations
Share

Fundraising

Raising capital for your business

Breadcrumb

  • Home
  • OC Ventures
  • Fundraising

Helping you create, build and grow your business from initial start up through to growth and beyond.

Osborne Clarke's Venture and Growth capital practice is a market leader in the technology and life sciences sectors in Europe. 

We advise companies and investors on more than 100 sub-£5 million fundraisings a year and 400-plus venture and growth funding rounds of between £10 million to £100 million a year.

Our role in these deals is evenly split between advising investee companies and investors and this gives us an unrivalled knowledge of the venture capital market and a scale and depth of experience to deliver any fundraising transaction smoothly and efficiently

Fund establishment and ongoing advice
Our funds team can assist in the design and launch of a new fund structure for an investor, aligning the structure to the investor's specific needs. Our advice on fund formation can additionally encompass entity incorporation, preparation of constitutional documentation, regulatory advice, service-provider relationship negotiation and tax planning. 

Fundraising strategy and advice
We can provide preliminary advice to founders and management teams on how a fundraising will work, different types of investment, strategic advice and guidance on preparatory steps. We also regularly provide advice and guidance to investors on current market practice on deal terms and structures. Find out more here.

Investment documentation
We can assist on the drafting and negotiation of heads of terms, subscription and shareholders' or investment agreements and articles of association, providing market appropriate and sensible advice on negotiations and the documents. Find out more here.

Convertible loans and advance subscriptions, ASAs (Advanced Subscription Agreements), SAFE (Simple Agreement for Future Equity)
Our team drafts and advises investors and companies on all forms of convertibles, including on current market practice and tax treatment where relevant. Find out more here. 

Due diligence
We can undertake pre-investment reviews to ensure a company is clean and investment ready, using our experience to focus on typical investor red flags and handle relevant remedial steps. We also provide our own virtual data room facility and carry out formal due diligence reviews pre-investment for our investor clients, covering UK and international aspects of any target business as needed. 

Tax advice
Our Tax team advises investors and companies on qualification for Venture Capital Trusts, the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme (SEIS). The team can also provide tax advice in respect of investments by founders, managers and other individuals related to their personal tax position.
Find out more here >

Project management and technology
To ensure a painless and efficient process for our clients, we exemplify project-management best practice and take advantage of available technologies in relation to drafting, project management and document execution to ensure a smooth and efficient transaction process and completion. 

Venture and growth debt
We are well versed with the different venture and growth lending products available including term loans, receivables based financings and recurring revenue facilities.
Find out more here >

Home
Find out more
Find out more
Find out more
Find out more
Find out more
Find out more
Find out more
Find out more

Work highlights from across the ventures ecosystem

AlbionVC

We advised AlbionVC as Toqio has secured £17.2m in Series A funding, which also includes a £1.1m grant from a public organisation for technology development in Spain. 

Learn more
AlbionVC

We advised AlbionVC as the world's first cybersecurity human risk management platform, OutThink, which combines machine learning, natural language processing and applied psychology to identify individuals' attitudes and behaviours, has raised £8.8 million in its latest funding round. 

Learn more
Argonaut Therapeutics Ltd

We advised Argonaut Therapeutics Ltd on its merger with Celleron Therapeutics Ltd. 

Learn more
Foresight

We advised Foresight, a leading listed regional private equity and infrastructure investment manager, on the first close of its Foresight Scotland Fund.

Learn more
UCL Technology Fund

We advised UCL Technology Fund on lead investment in Bloomsbury Genetic Therapies' £5 million financing round.

Learn more
BGF

We advised BGF on its investment in autonomous vehicle software global leader Oxbotica's Series C funding round raising US$140 million. The funding will be used to drive Oxbotica's global expansion and accelerate commercialisation of its technology. 

Learn more
Mediktor

We advised digital health startup Mediktor in an 11m euro series B round led by Swiss fund MTIP. We already advised Mediktor in their 3m euro series A round led by Alta Life Sciences. 

Giant Ventures

We advised on the establishment of Giant Ventures and the launch of its Fund I and Fund II.

Factorial

We advised Barcelona-based HR SaaS developer Factorial in an $80m series B finance round, led by Tiger Global, with co-investment by funds Creandum and CRV.

Mangrove Capital Partners and 14W

We advised Mangrove Capital Partners and 14W as lead investors in a $30m finance round in online travel agency Exoticca.

Accel and 14W

We advised Accel and 14W on an $181m series F funding round led by Korelya as investors in second-hand marketplace Wallapop. 

Epitopea

Advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité FTQ in US$13.6 million funding round.

Learn more
Pink Salt Ventures

We advised on the establishment of Pink Salt Ventures and the launch of its first fund. 

Optellum

Advised pioneering AI lung cancer diagnosis innovator Optellum on US$14m Series A funding round.

Learn more
Advent Life Sciences

We advised Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, on its lead investment in Proximie's US$80 million Series C funding round. 

Learn more
Super Payments

We advised Super Payments on its £22.5 million fundraise led by Accel to transform the online shopping experience. 

Learn more
Causeway Technologies

Advised Causeway Technologies on a £120 million investment to fund strategic acquisitions and accelerate its organic growth strategy to digitally connect the construction supply chain through further development of its Cloud Platform. 

Learn more
Highland Europe and Frog Capital

We advised Highland Europe and Frog Capital on additional investment in Modulr an embedded payments platform for digital businesses. 

Learn more
Foresight Group

We advised on the launch of the Foresight Williams joint venture (and Foresight Williams EIS Fund). 

Highland Europe

Advised Highland Europe on its series C$100 million investment in SaaS platform Plentific. 

Learn more
N26

Osborne Clarke advises N26 in billion-dollar funding round with top investors.

Learn more
Fintern

We advised Fintern on fundraising as it secures £40 million of capital. Investment will help scale its credit technology and power fair finance across the UK and beyond. 

Learn more
Nexeon Limited

We advised Nexeon on significant US$80 million funding to scale up production of step change battery materials. Through the transaction, Nexeon enters into a strategic partnership with SKC, a major global battery and semiconductor 

Learn more
Eight Roads

We advised Eight Roads on its lead in 7bridges' $17 million Series A fundraising round. Eight Roads led the round together with Local Globe and enterprise VC Crane. With this round 7 bridges has raised just over $20 million to date.

Learn more
DoorDash

Osborne Clarke has advised DoorDash on USD 750 million Series B financing round of rapid delivery firm Flink SE.

Learn more
Warburg Pincus and Hollyport Capital

Osborne Clarke advised Warburg Pincus and Hollyport Capital on Series D financing round of McMakler.

Learn more
Tiger Global

We advised Tiger Global on its lead investment in Lifebit's $60 million series B funding round. The round will field the rapid adoption of biomedical software around the world. 

Learn more
Science Creates Ventures, Foresight Williams Technology and BGF

We advised Science Creates Ventures, Foresight Williams Technology and BGF on their involvement in Forefront RF's initial £1.5 million investment round, which also included The Cambridge Angels. 

Learn more
Flock

We advised Flock on $17 million fundraise led by social capital to reinvent insurance for connected vehicles. A funding to supercharge its expansion into new geographies and product lines. 

Learn more
BGF

We advised BGF on its lead investment in a £58 million funding of disruptive femtech firm Elvie, the revolutionary global health and lifestyle brand developing iconic products for women. 

Learn more
Passion Capital

We advised on the launch of Passion Capital's third venture fund. 

Element Ventures

We advised Element Ventures, a global venture capital fund, as the lead investor in Coincover's $9.2 million Series A round. The funding will be used to drive awareness of the product offering and grow the team so that Coincover can support more of the crypto market. 

Learn more
NeRRe Therapeutics

We advised NeRRe Therapeutics on its £20 million Series B2 financing round. The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners and existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed. 

Learn more
BGF and CPT Capital

We advised BGF and CPT Capital on a £11 million equity fundraising round for THIS, a plant-based, meat alternative brand.

Learn more
Thirdfort

We advised digital onboarding platform, Thirdfort, on its latest £1.5 million fund raising. Leading digital entrepreneur Alex Chesterman is among the high profile names to have reinvested. The funding will support expansion in the legal and property sectors for the digital ID and anti-money-laundering start up.  

Learn more
Illuminate Financial Management

We advised on the launch of all of Illuminate's funds (three in total), focusing on early-stage investments in the global capital markets Fintech market. 

Learn more
BGF

We advised BGF on a £10.5 million minority investment in e2e-assure, an established, fast-growth cybersecurity. The Funding will be used to facilitate international growth and expand its go-to marketing offering. 

Learn more
Science Creates Ventures

We advised on the establishment of Science Creates Ventures and the launch of its first fund. 

Learn more
Amphista Therapeutics

We advised Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, on its $53 million (£38 million) Series B financing round. 

Learn more
Monashees

We advised Brazilian venture capital manager Monashees, on its lead investment in AI energy analytics start-up Vortexa's $19m Series B investment round. 

Learn more
Firstminute Capital

We advised firstminute capital on the launch of firstminute capital I, and firstminute capital II as well as series of SPV LP's.

Learn more
Clean Growth Fund

We advised the Clean Growth Fund on a £6 million co-investment with Gulf Oil in Indra, the UK's leading smart charging technology company. 

Learn more
Firstminute

We advised on the launch of the second early-stage technology fund from firstminute capital raising $111 million to date. 

Learn more
BFG

We advised BFG on its £6 million investment in Amdaris, an industry-leading software developer and digital transformation specialist, to support its organic and acquisitive growth strategy. 

Learn more
InReach Adventures

We advised InReach on the launch of their first fund targeting seed and pre Series A investments in European technology companies.

Learn more
MMC Ventures

We advised MMC on the launch of the MMC Greater London Fund and the MMC Scale up Fund 2019 as well as a series of SPV LP's. 

Notion Capital

We advised on the the launch of all of Notion's UK-based venture and growth capital funds. 

PiLabs

We advised on the launch of PiLabs' third European proptech fund. 

Connect with one of our experts

Justin Starling
Partner, UK
+44 118 925 2090 Email Justin Full biog
Rob Hayes
Partner, UK
+44 118 925 2060 Email Rob Full biog
Herke van Hulst
Partner, Advocaat, The Netherlands
+31 207028672 Email Herke Full biog
Mikael Nelson
Partner, Sweden
+46 709 555 059 Email Mikael Full biog
Helen Parsonage
Partner, UK
+44 117 917 3432 Email Helen Full biog
David Miranda
Partner, Spain
+34 93 419 18 18 Email David Full biog
Nicolas Gabrysch
Partner, Germany
+49 221 5108 4178 Email Nicolas Full biog
James Taylor
Associate Director, UK
+44 117 917 3180 Email James Full biog
Elizabeth Yell
Associate Director, UK
+44 118 925 2091 Email Elizabeth Full biog
Josephine Healy-Russell
Senior Associate, UK
+44 207 105 7710 Email Josephine Full biog
Robert Pook
Associate Director, UK
+44 118 925 2049 Email Robert Full biog
Ben Cocoracchio
Associate Director, UK
+44 20 7105 7037 Email Ben Full biog
Elinor Owen
Associate Director, UK
+44 117 917 4288 Email Elinor Full biog
Kamila Bochenek
Associate, UK
+44 207 105 7844 Email Kamila Full biog

Explore

  • People
  • Sectors
  • Transformation
  • Services
  • Insights
  • Events
  • Locations

Useful links

  • Site map
  • Terms and conditions
  • Contact us
  • Privacy policy
  • California Privacy Notice
  • Slavery statement
  • Alumni
  • Cookie policy
  • Transparency

Sign up for our newsletter

Register now for more insights, news and events from across Osborne Clarke.
Sign up

Follow us

Osborne Clarke
Legal Notice
When you read about Osborne Clarke on this site, we are either referring to our international organisation, Osborne Clarke Verein (OCV), or one of its member firms. OCV is a Swiss verein and doesn’t provide services to clients. The OCV member firms are all separate legal entities and have no authority to obligate or bind each other or OCV with regard to third parties. To find out more, please click here.